NCT07009873 Clinical Application of Wearable Ultrasound Sensors
| NCT ID | NCT07009873 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese PLA General Hospital |
| Condition | DVT - Deep Vein Thrombosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-08-15 |
| Primary Completion | 2026-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-08-15 with a primary completion date of 2026-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop and evaluate a wearable ultrasound imaging sensor for the early diagnosis and real-time monitoring of various diseases, such as cardiovascular conditions and structural abnormalities of superficial organs. With advancements in medical technology, wearable devices have attracted increasing attention for their portability and real-time capabilities.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 yrs and able to consent * Relevant diagnosis for study arm (heart failure, lower-limb DVT, or ICU monitoring) * Adequate acoustic window and intact skin at sensor site Arm-specific: * Heart-failure arm: Clinically stable HFrEF or HFpEF on standard therapy * DVT arm: Imaging-confirmed lower-limb DVT, anticoagulated or scheduled for intervention * ICU arm: ICU/post-op patient requiring continuous bedside ultrasound Exclusion Criteria: * Poor acoustic window preventing interpretable images * Local skin infection, open wound, or implant/hardware blocking sensor * Inability to cooperate with monitoring Arm-specific: * Heart-failure arm: Acute MI or uncontrolled arrhythmia in past 3 months * DVT arm: Active bleeding or severe coagulopathy * ICU arm: Unstable multi-organ failure precluding safe monitoring
Contact & Investigator
Yukun Luo, Professor, M.D.
PRINCIPAL INVESTIGATOR
Chinese PLA General Hospital
Frequently Asked Questions
Who can join the NCT07009873 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying DVT - Deep Vein Thrombosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07009873 currently recruiting?
Yes, NCT07009873 is actively recruiting participants. Contact the research team at 248597504@qq.com for enrollment information.
Where is the NCT07009873 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07009873 clinical trial?
NCT07009873 is sponsored by Chinese PLA General Hospital. The principal investigator is Yukun Luo, Professor, M.D. at Chinese PLA General Hospital. The trial plans to enroll 300 participants.